NSC 756093
|
|
- CAS-Nr.
- 1629908-92-4
- Englisch Name:
- NSC 756093
- Synonyma:
- NSC 756093;NSC756093 >=98% (HPLC);NSC756093, 10 mM in DMSO;4-(2-hydroxyethyl)-6-methoxy-9-phenyl-3,9-dihydrofuro[3,4-b]quinolin-1-one;4,9-Dihydro-4-(2-hydroxyethyl)-6-methoxy-9-phenylfuro[3,4-b]quinolin-1(3H)-one;4-(2-Hydroxyethyl)-6-methoxy-9-phenyl-4,9-dihydrofuro[3,4-b]quinolin-1(3H)-one;Furo[3,4-b]quinolin-1(3H)-one, 4,9-dihydro-4-(2-hydroxyethyl)-6-methoxy-9-phenyl-;paclitaxel resistant,anticancer,NSC756093,ovarian cancer,NCI-60 cell,inhibit,SKOV3 cells,Inhibitor
- CBNumber:
- CB93146344
- Summenformel:
- C20H19NO4
- Molgewicht:
- 337.37
- MOL-Datei:
- 1629908-92-4.mol
|
NSC 756093 Eigenschaften
- Siedepunkt:
- 561.8±50.0 °C(Predicted)
- Dichte
- 1.35±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- L?slichkeit
- DMSO: soluble
- Aggregatzustand
- A solid
- pka
- 14.56±0.10(Predicted)
- Farbe
- White to off-white
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
NSC 756093 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
NSC756093 is the first inhibitor of the GBP1 and PIM1 interaction.
NSC 756093 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
NSC 756093 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 26)Lieferanten
- NSC 756093
- 4-(2-hydroxyethyl)-6-methoxy-9-phenyl-3,9-dihydrofuro[3,4-b]quinolin-1-one
- NSC756093 >=98% (HPLC)
- paclitaxel resistant,anticancer,NSC756093,ovarian cancer,NCI-60 cell,inhibit,SKOV3 cells,Inhibitor
- Furo[3,4-b]quinolin-1(3H)-one, 4,9-dihydro-4-(2-hydroxyethyl)-6-methoxy-9-phenyl-
- 4-(2-Hydroxyethyl)-6-methoxy-9-phenyl-4,9-dihydrofuro[3,4-b]quinolin-1(3H)-one
- 4,9-Dihydro-4-(2-hydroxyethyl)-6-methoxy-9-phenylfuro[3,4-b]quinolin-1(3H)-one
- NSC756093, 10 mM in DMSO
- 1629908-92-4